The other previous study of oral sodium ferrous citrate in hemodialysis patients with iron deficiency reported a decrease in iFGF23, cFGF23, dose of ESA, and CRP levels without changes in serum phosphorus [37]. This evidence concerns the gene CRP and nutritional disorder.